Skip to main content

Tourmaline Bio, Inc.

TRMLDelisted Oct 28, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001827506

Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Tourmaline Bio, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of TRML: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders050+50
Shares026.0M+26.0M
Value$0$379.4M+$379.4M

New holders (50)

Institutions that held Tourmaline Bio, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to TRML in Q2 2021
InstitutionSharesValue% of portfolio
Blackstone Group Inc.8,089,315$118.8M0.28%
Viking Global Investors LPSuperinvestorViking Global Investors3,289,617$48.3M0.15%
Citadel Advisors LLC2,670,326$38.1M0.04%
Artal Group S.A.2,064,262$30.3M0.69%
BlackRock Inc.1,773,127$26.0M0.00%
Eventide Asset Management, LLC1,561,092$22.4M0.30%
Cormorant Asset Management, LP1,215,847$17.3M0.67%
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)853,344$12.5M0.13%
Sectoral Asset Management Inc711,000$10.4M0.85%
Aisling Capital Management LP682,923$10.0M1.61%
Logos Global Management LP507,923$7.46M0.64%
Avidity Partners Management LP436,363$6.41M0.17%
Vanguard Group Inc390,826$5.74M0.00%
Laurion Capital Management LP298,422$4.38M0.07%
OrbiMed Advisors LLC247,240$3.63M0.04%
Woodline Partners LP206,159$3.03M0.06%
Geode Capital Management, LLC154,063$2.26M0.00%
Tudor Investment Corp Et Al98,949$1.45M0.03%
State Street Corp94,962$1.40M0.00%
Northern Trust Corp92,784$1.36M0.00%
Caas Capital Management LP90,000$1.32M0.07%
FMR LLC60,000$881.0K0.00%
Alyeska Investment Group, L.P.50,000$735.0K0.01%
Two Sigma Investments, LP44,967$661.0K0.00%
D. E. Shaw & Co., Inc.39,039$573.0K0.00%
Clough Capital Partners L P33,600$494.0K0.03%
Monashee Investment Management LLC25,000$367.0K0.04%
Zimmer Partners, LP23,331$343.0K0.00%
Two Sigma Advisers, LP23,100$339.0K0.00%
Charles Schwab Investment Management Inc22,410$330.0K0.00%
Morgan Stanley18,253$269.0K0.00%
Bank of New York Mellon Corp16,779$246.0K0.00%
Nuveen Asset Management, LLC14,098$207.0K0.00%
JPMorgan Chase & Co13,129$193.0K0.00%
California State Teachers Retirement System12,320$181.0K0.00%
Ghisallo Capital Management LLC10,000$147.0K0.01%
Cubist Systematic Strategies, LLC9,920$146.0K0.00%
New York State Common Retirement Fund7,600$112.0K0.00%
UBS Group AG5,691$84.0K0.00%
Deutsche Bank AG5,288$78.0K0.00%
American International Group, Inc.4,991$73.0K0.00%
Bank of America Corp4,054$59.0K0.00%
STRS Ohio2,100$30.0K0.00%
Legal & General Group Plc858$13.0K0.00%
Ameritas Investment Partners, Inc.698$10.0K0.00%
Point72 Hong Kong Ltd675$10.0K0.00%
Royal Bank of Canada609$9.00K0.00%
Citigroup Inc510$7.00K0.00%
First Horizon Advisors, Inc.250$4.00K0.00%
Tower Research Capital LLC (TRC)62$1.00K0.00%

Sold out (0)

Institutions that held Tourmaline Bio, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

None.